We are live on ! Find out more
AI

Alphabet Inc Portfolio holdings

AUM $4.02B
1-Year Est. Return 215.74%
This Fund
S&P 500
This Quarter Est. Return
+31.04%
1 Year Est. Return
+215.74%
3 Year Est. Return
+350.01%
5 Year Est. Return
+242.03%
10 Year Est. Return
+998.87%
AUM
$1.96B
AUM Growth
+$116M
Cap. Flow
-$165M
Cap. Flow %
-8.45%
Top 10 Hldgs %
78.41%
Holding
55
New
–
Increased
1
Reduced
2
Closed
6

Top Buys

Rank Stock Value
1
DUOL icon
Duolingo
DUOL
+$54.5M

Top Sells

Rank Stock Value
1
DXCM icon
DexCom
DXCM
+$185M
2
TOST icon
Toast
TOST
+$18.5M
3
IDYA icon
IDEAYA Biosciences
IDYA
+$10.4M
4
OMIC
Singular Genomics Systems, Inc. Common Stock
OMIC
+$2.24M
5
VLD
Velo3D, Inc.
VLD
+$1.71M

Sector Composition

Rank Sector Weight
1 Healthcare 58.06%
2 Technology 25.64%
3 Industrials 11.3%
4 Financials 2.56%
5 Consumer Staples 2.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VERA icon
26
Vera Therapeutics
VERA
$2.3B
$6.43M 0.33%
301,580
– –
DBTX
27
DELISTED
Decibel Therapeutics, Inc. Common Stock
DBTX
$5.66M 0.29%
1,636,258
– –
NEWR
28
DELISTED
New Relic, Inc.
NEWR
$5.23M 0.27%
91,132
– –
SNCE
29
DELISTED
Science 37 Holdings, Inc. Common Stock
SNCE
$5.16M 0.26%
160,363
– –
BRNS
30
Barinthus Biotherapeutics
BRNS
$22.8M
$4.84M 0.25%
1,513,644
– –
KRON
31
DELISTED
Kronos Bio
KRON
$4.82M 0.25%
1,438,232
– –
DNTH icon
32
Dianthus Therapeutics
DNTH
$5.84B
$4.71M 0.24%
208,696
– –
FHTX icon
33
Foghorn Therapeutics
FHTX
$266M
$4.3M 0.22%
500,901
– –
TCRX icon
34
TScan Therapeutics
TCRX
$48.6M
$3.29M 0.17%
1,077,080
– –
AMPL icon
35
Amplitude
AMPL
$1.18B
$2.93M 0.15%
189,447
– –
TNYA icon
36
Tenaya Therapeutics
TNYA
$161M
$2.66M 0.14%
915,705
– –
EVLO
37
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
$2.22M 0.11%
53,025
– –
FULC icon
38
Fulcrum Therapeutics
FULC
$273M
$2.07M 0.11%
255,452
– –
SPRO icon
39
Spero Therapeutics
SPRO
$67.7M
$1.78M 0.09%
889,979
– –
ALEC icon
40
Alector
ALEC
$168M
$1.66M 0.09%
175,866
– –
AUTL
41
Autolus Therapeutics
AUTL
$397M
$1.49M 0.08%
698,262
– –
TSHA icon
42
Taysha Gene Therapies
TSHA
$1.68B
$1.24M 0.06%
640,882
– –
EXAS
43
DELISTED
Exact Sciences
EXAS
$754K 0.04%
23,205
– –
HYPR icon
44
Hyperfine
HYPR
$92.9M
$728K 0.04%
898,720
– –
NVTA
45
DELISTED
Invitae Corporation
NVTA
$529K 0.03%
215,965
– –
OPRT icon
46
Oportun Financial
OPRT
$255M
$414K 0.02%
94,788
– –
QNCX icon
47
Quince Therapeutics
QNCX
$22.9M
$252K 0.01%
946
– –
HLTH
48
DELISTED
Cue Health Inc. Common Stock
HLTH
$81K ﹤0.01%
27,000
– –
RGEN icon
49
Repligen
RGEN
$7.96B
$72K ﹤0.01%
383
– –
IDYA icon
50
IDEAYA Biosciences
IDYA
$3.42B
– –
-753,187
Closed -$10.4M
1
2
3

Similar funds

JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
MAM
Martingale Asset Management Boston, Massachusetts $3.99B AUM 22.65% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
USCWA
U.S. Capital Wealth Advisors Austin, Texas $3.98B AUM 22.36% 1-Year Est. Return
ICP
Ilex Capital Partners London, United Kingdom $4.06B AUM 6.11% 1-Year Est. Return
CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
MGP
Metis Global Partners San Diego, California $4.07B AUM 30.82% 1-Year Est. Return

Alphabet Inc's Q3 2022 Portfolio in Review

As of Q3 2022, Alphabet Inc held 55 positions worth $1.96B, up 6.3% from $1.84B the previous quarter. Its ten largest holdings account for 78% of the portfolio.

Alphabet Inc withdrew a net $165M in Q3 2022, closing 6 positions and reducing 2 holdings. Its most notable exit was Toast, an estimated $18.5M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 58% of assets, up from 57% a quarter earlier, followed by Technology and Industrials.

Against the trend, Alphabet Inc added an estimated $54.5M to Duolingo.

  • Alphabet Inc added most to Duolingo in Q3 2022, an estimated $54.5M increase.
  • Alphabet Inc's biggest Q3 2022 reduction was DexCom, cutting an estimated $185M.
  • Alphabet Inc fully exited Toast in Q3 2022, selling an estimated $18.5M.
  • Alphabet Inc's ten largest holdings make up 78% of its $1.96B portfolio in Q3 2022.
  • Alphabet Inc opened 0 new positions and closed 6 in Q3 2022.
  • Alphabet Inc's portfolio value rose 6.3% quarter-over-quarter to $1.96B.

Based on Alphabet Inc's 13F filing for Q3 2022, filed 15 Nov 2022.